Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1979 1
1981 1
1983 1
1988 2
1989 2
1990 9
1991 5
1992 4
1993 2
1994 6
1995 3
1996 6
1997 7
1998 1
1999 4
2000 6
2001 4
2002 1
2003 6
2005 6
2006 5
2007 3
2008 5
2009 1
2010 5
2011 6
2012 1
2013 1
2015 1
2016 1
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

104 results

Results by year

Filters applied: . Clear all
Page 1
Faculty development: doing more with less.
Barksdale DJ, Woodley L, Page JB, Bernhardt J, Kowlowitz V, Oermann MH. Barksdale DJ, et al. Among authors: page jb. J Contin Educ Nurs. 2011 Dec;42(12):537-44; quiz 545-6. doi: 10.3928/00220124-20110301-94. Epub 2011 Mar 8. J Contin Educ Nurs. 2011. PMID: 21410085
Human immunodeficiency virus type 1 pharmacogenomics in clinical practice: relevance of HIV-1 drug resistance testing (Part 2).
Patarca R, Isava A, Campo R, Rodriguez NJ, Nunez E, Alter M, Marchette M, Sanabia MM, Mitchell C, Rivera D, Scott G, Jayaweera D, Moreno J, Boulanger C, Kolber M, Mask CW, Sierra EM, Vallejo R, Page JB, Klimas NG, Fletcher M. Patarca R, et al. Among authors: page jb. J Environ Pathol Toxicol Oncol. 2003;22(4):235-79. doi: 10.1615/jenvpathtoxoncol.v22.i4.10. J Environ Pathol Toxicol Oncol. 2003. PMID: 14669906 Review.
Human immunodeficiency virus type 1 pharmacogenomics in clinical practice: relevance of HIV-1 drug resistance testing (Part 1).
Patarca R, Isava A, Campo R, Rodriguez NJ, Nunez E, Alter M, Marchette M, Sanabia MM, Mitchell C, Rivera D, Scott G, Jayaweera D, Moreno J, Boulanger C, Kolber M, Mask CW, Sierra EM, Vallejo R, Page JB, Klimas NG, Fletcher MA. Patarca R, et al. Among authors: page jb. J Environ Pathol Toxicol Oncol. 2003;22(3):201-34. doi: 10.1615/jenvpathtoxoncol.v22.i3.40. J Environ Pathol Toxicol Oncol. 2003. PMID: 14529094 Review.
Molecular and contextual markers of hepatitis C virus and drug abuse.
Shapshak P, Somboonwit C, Drumright LN, Frost SD, Commins D, Tellinghuisen TL, Scott WK, Duncan R, McCoy C, Page JB, Giunta B, Fernandez F, Singer E, Levine A, Minagar A, Oluwadara O, Kotila T, Chiappelli F, Sinnott JT. Shapshak P, et al. Among authors: page jb. Mol Diagn Ther. 2009;13(3):153-79. doi: 10.2165/01250444-200913030-00002. Mol Diagn Ther. 2009. PMID: 19650670 Free PMC article. Review.
104 results